NCT04549805View on ClinicalTrials.gov

Troponin to Risk Stratify Patients for Computed Tomography Coronary Angiography

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

October 6, 2020

Study Completion Date

October 6, 2020

Conditions
Coronary Artery DiseaseAcute Coronary Syndrome
Interventions
DIAGNOSTIC_TEST

Computed Tomography Coronary Angiography

In order to optimise the quality of the Computed Tomography Coronary Angiography scan images, participants might be given tablets or an injection (e.g. beta-blockers, calcium channel antagonist, ivabradine) to slow their heart rate and glyceryl trinitrate (GTN) following local protocol guidance.

Trial Locations (1)

EH16 4SB

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh

All Listed Sponsors
collaborator

NHS Lothian

OTHER_GOV

collaborator

British Heart Foundation

OTHER

lead

University of Edinburgh

OTHER

NCT04549805 - Troponin to Risk Stratify Patients for Computed Tomography Coronary Angiography | Biotech Hunter | Biotech Hunter